1-7 of 7
Cendrine Chaffaut
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Final Results of Ruxopeg, a Phase 1/2 Adaptive Randomized Trial of Ruxolitinib (Rux) and Pegylated Interferon Alpha (IFNa) 2a in Patients with Myelofibrosis (MF)

Jean-Jacques Kiladjian, Jean-Christophe Ianotto, Juliette Soret, Nabih Maslah, Cendrine Chaffaut, Françoise Boyer perrard, Fiorenza Barraco, Viviane Dubruille, Claude Capron, Amandine Tisserand, Valérie Rolland-Neyret, Zineb Ghrieb, Sylvie Chevret, Isabelle Plo, Marie-Hélène Schlageter, Veronique Meignin, Matthieu Resche-Rigon, Bruno Cassinat
Journal: Blood
Blood (2022) 140 (Supplement 1): 577–578.
https://doi.org/10.1182/blood-2022-156389
Published: 2022
Journal Articles

Ivosidenib Monotherapy Is Effective in Patients with IDH1 Mutated Myelodysplastic Syndrome (MDS): The Idiome Phase 2 Study By the GFM Group

Marie Sebert, Thomas Cluzeau, Odile Beyne Rauzy, Aspasia Stamatoulas Bastard, Sophie Dimicoli-Salazar, Sylvain Thepot, Pierre Peterlin, Sophie Park, Marie-Pierre Gourin, Oana Brehar, Cécile Bally, Sébastien Maury, Gaelle Fossard, Lamya Ait Si Selmi, Cendrine Chaffaut, Emmanuelle Clappier, Raphael Itzykson, Fatiha Chermat, Sylvie Chevret, Pierre Fenaux, Lionel Ades
Journal: Blood
Blood (2021) 138 (Supplement 1): 62.
https://doi.org/10.1182/blood-2021-146932
Published: 2021
Journal Articles

Allogeneic Hematopoietic Stem Cell Transplantation (allo HSCT) in Patients with IPSS Low or Intermediate-1 Myelodysplastic Syndrome (MDS): A Prospective Multicenter Phase II Study Based on Donor Availability By the GFM & SFGM-TC "MDS-ALLO-Risk"

Marie Sebert, Cendrine Chaffaut, Sylvain Thepot, Corentin Orvain, Thomas Cluzeau, Michael Loschi, Pierre Peterlin, Patrice Chevallier, Maud d'Aveni, Marie-Thérèse Rubio, Odile Beyne Rauzy, Anne Huynh, Amandine Charbonnier, Nathalie Fegueux, Gaelle Fossard, Stephanie N'guyen-Quoc, Sophie Park, Rosa Sapena, Fatiha Chermat, Lionel Ades, Sylvie Chevret, Pierre Fenaux, Marie Robin
Journal: Blood
Blood (2021) 138 (Supplement 1): 1842.
https://doi.org/10.1182/blood-2021-146846
Published: 2021
Journal Articles

Decitabine Versus Hydroxyurea for Advanced Proliferative CMML: Results of the Emsco Randomized Phase 3 Dacota Trial

Raphael Itzykson, MD PhD, Valeria Santini, Cendrine Chaffaut, Ades Lionel, Sylvain Thepot, MD, Aristoteles Giagounidis, Margot Morabito, Nathalie Droin, Michael Luebbert, Rosa Sapena, Stanislas Nimubona, MD, Jean E. Goasguen, MD PhD, Eric Wattel, MD PhD, Gina Zini, MDPhD, Jose Miguel Torregrosa Diaz, Ulrich Germing, Anna Maria Pelizzari, Sophie Park, MD PhD, Nadja Jaekel, Georgia Metzgeroth, Francesco Onida, MD, Robert Navarro, Andrea Patriarca, MD, Aspasia Stamatoulas Bastard, MD, Martin Puttrich, Sandra Mossuto, Eric Solary, MD PhD, Silke Gloaguen, Msc, Sylvie Chevret, MD PhD, Fatiha Chermat, Uwe Platzbecker, Pierre Fenaux, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 53–54.
https://doi.org/10.1182/blood-2020-138680
Published: 2020
Journal Articles

Results of a Phase II Study of Guadecitabine (SGI-110) in Higher Risk MDS, CMML or Low Blast Count AML Patients Refractory to or Relapsing after Azacitidine (AZA) Treatment

Marie Sebert, MD, Cecile Bally, Pierre Peterlin, MD, Odile Beyne-Rauzy, MD PhD, Laurence Legros, MDPhD, marie Pierre Gourin, MD PhD, Laurence Sanhes, MD, Eric Wattel, MDPhD, Emmanuel Gyan, MD PhD, Sophie Park, MD PhD, Aspasia Stamatoullas, MD, Anne Banos, Kamel Laribi, Simone Jueliger, PhD, Luke Bevan, Cendrine Chaffaut, Rosa Sapena, Benedicte Samey, Fatiha Chermat, Sylvie Chevret, Lionel Ades, MD PhD, Pierre Fenaux, MD PhD
Journal: Blood
Blood (2016) 128 (22): 347.
https://doi.org/10.1182/blood.V128.22.347.347
Published: 2016
Journal Articles

Azacitidine (AZA) Combined with Idarubicin in Higher Risk MDS - Results of a Phase I/II Study By the Groupe Francophone Des Myelodysplasies (GFM)

Marie Sebert, MD, Aspasia Stamatoullas, MD, Thorsten Braun, MD PhD, Jacques Delaunay, MD, Benoît de Renzis, Ramzi Jeddi, MD, Balkis Meddeb, Mathilde Hunault Berger, Benedicte Samey, Fatiha Chermat, Sylvie Chevret, Cendrine Chaffaut, Pierre Fenaux, MD PhD, Lionel Ades, MD PhD
Journal: Blood
Blood (2015) 126 (23): 2884.
https://doi.org/10.1182/blood.V126.23.2884.2884
Published: 2015
Journal Articles

A Phase I-II Study Of The Efficacy and Safety Of Lenalidomide (LEN) Combined To Azacitidine (AZA) In Higher Risk MDS and AML With Del 5q – A Study By The Groupe Francophone Des Myelodysplasies (GFM)

Lionel Ades, Christian Recher, MD PhD, Aspasia Stamatoullas, Krimo Bouabdallah, MD, Jacques Delaunay, MD, Francois Dreyfus, MD, Norbert Vey, MD PhD, Benoit de Renzis, Emmanuel Raffoux, Françoise Isnard, MD, Benedicte Samey, Cendrine Chaffaut, Sylvie Chevret, Pierre Fenaux, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 2750.
https://doi.org/10.1182/blood.V122.21.2750.2750
Published: 2013